Medtronic plc. (MDT) - 5i Research

Medtronic plc. (MDT $85.00)
- $85.00 P/E (TTM): 24.08X Cap: $109.13B
- View MDT Profile
- View Questions on MDT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Medtronic plc. (MDT $85.00)
- $85.00 P/E (TTM): 24.08X Cap: $109.13B
- View MDT Profile
- View Questions on MDT

Q: In a recent article that I read, the focus was on filtering “companies with expected ROE expansion driven by improving margins and total asset turnover, not financial engineering.”

Among those at the top of his list, the one that interested me was MDT.

- Do you agree that MDT should see favourable ROE going forward?

- Any concerns about valuation or competition?

- Would you agree that the requirement for MDT's devices would be more resilient during recessionary times compared to other types of surgeries?

Read Answer Asked by James on March 27, 2026

Alphabet Inc. (GOOG $335.40)
- $335.40 P/E (TTM): 31.4X Cap: $4.13T
- View GOOG Profile
- View Questions on GOOG
NVIDIA Corporation (NVDA $202.06)
- $202.06 P/E (TTM): 41.16X Cap: $4.91T
- View NVDA Profile
- View Questions on NVDA
QUALCOMM Incorporated (QCOM $137.52)
- $137.52 P/E (TTM): 27.46X Cap: $146.73B
- View QCOM Profile
- View Questions on QCOM
Eli Lilly and Company (LLY $919.90)
- $919.90 P/E (TTM): 40.39X Cap: $869.13B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $85.00)
- $85.00 P/E (TTM): 24.08X Cap: $109.13B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $338.34)
- $338.34 P/E (TTM): 40.77X Cap: $131.48B
- View SYK Profile
- View Questions on SYK

Q: Could have I an update on your views on Medtronic’s and Qualcomm. Its hold in a RRSP. Would you suggest 1-2 companies for each one with better or same risk profile you would suggest to switch for if you think that’s a good idea .

Read Answer Asked by Olivier on March 17, 2026

Medtronic plc. (MDT $85.00)
- $85.00 P/E (TTM): 24.08X Cap: $109.13B
- View MDT Profile
- View Questions on MDT

Q: Bloomberg Headline-- Medtronic Unit Raises $560 Million in US IPO Priced Below Range.
Is it the spinoff unit that investors are not interested in or MDT as a company?
I thought MDT had positive momentum but it looks otherwise. The price today is lower than when we bought in 2020. We were holding on thinking that the firm would harness AI. Do you see any evidence that they are? Or that they could, and improved their performance? Would you hold on or let go? Many thanks for your views

Read Answer Asked by TOM on March 10, 2026